title: Specific destruction of allogeneic tumor cells in vivo by a bismuth-212 immunotoxin.
authors.affiliation: University of Chicago, IL 60637.
authors.forename: F P
authors.initials: FP
authors.lastname: Stuart
authors.forename: G
authors.initials: G
authors.lastname: Perdrizet
authors.forename: B
authors.initials: B
authors.lastname: Steranka
authors.forename: M
authors.initials: M
authors.lastname: Buckingham
authors.forename: D
authors.initials: D
authors.lastname: Lopes
authors.forename: V
authors.initials: V
authors.lastname: Alvarez
authors.forename: J
authors.initials: J
authors.lastname: Rodwell
authors.forename: T
authors.initials: T
authors.lastname: McKearn
authors.forename: J
authors.initials: J
authors.lastname: Hines
authors.forename: R
authors.initials: R
authors.lastname: Atcher
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use*; D000922:Immunotoxins / Q000627:therapeutic use*; D008223:Lymphoma / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D009368:Neoplasm Transplantation; D011868:Radioisotopes / Q000627:therapeutic use*; D051381:Rats; D011914:Rats, Inbred BN; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D011868:Radioisotopes; D001729:Bismuth